Tabor 4 building, Industrial Park
20692 Yokneam Elit, il
+972 (4) 9894884
Information in respect with transparency regulation
Total Capital - finden Sie im Anhang
Number of Voting Securities & voting rights ("Denominator")- The number of voting securities as of September 1, 2008 is 8,484,872 ordinary shares of NIS 0.1 par value each. The number of voting rights is 8,484,872 shares (the "denominator").
Number of Options and warrants - as of June 30, 2008 the Company has 873,429 options outstanding, each option when vested, can be converted into one ordinary share of NIS 0.1 par value. In addition, the Company has warrants to purchase shares of the Company for a total consideration of up to Euro 348,603 which may be exercised at any time, for a period ending at the earlier of 8.5 years after December 9, 2002 or 12 months after the consummation of an exit transaction as described in the agreement with the bank that hold the warrant. The exercise price will be the lower of Euro 1.3 or the price per share set at the exit transaction less 40%. In case of full exercise of the options and warrants, the number of outstanding shares will be increased by additional 1,141,585 shares and corresponding amount of 1,141,585 voting rights.
Convertible loan note - Following the "Summary of Terms of Convertible Loan Agreement" dated 11.9.07 ("Terms Sheet") Sheet signed between certain majority shareholders (the "Shareholders"), in connection with a convertible loan in the aggregate amount of $1,000,000 (the "Loan") provided by the Shareholders to the Company as discussed in the Company annual reports and in the reports of June 30, 2008. The Company's Shareholders have provided the remaining portion of the Loan in the amount of $400,000 further to the amount of $600,000 which has been provided before to the Company by the Shareholders which shall be convertible upon the terms and conditions set forth in the Terms Sheet.
According to the above mentioned Terms Sheet, any un-paid portion of the Loan and any interest due, shall be convertible by each Shareholder (for himself only) at his election in whole or in part until the earlier of (i) the end of the Term or (ii) the consummation of the Merger as defined in the Terms Sheet into Ordinary Shares of the Company, at a price per MediVision share reflecting a discount at the rate of 20% of MediVision's average share price on the EuroNext Stock Exchange during the 30 days immediately prior to conversion.
In case of conversion of the Loan the number of outstanding shares will be increased by approximately an additional amount of 1,197,000 shares and also an addition corresponding amount of 1,197,000 voting rights.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an email@example.com.